| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |